Fig. 10From: Diagnostic biomarker kinetics: how brain-derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100BSalivary levels in control or after BBB disruption. Note the delayed progression of salivary S100B towards steady state. Swallowing of saliva was not modeled for clarity and because nothing is known about the half-life of S100B in saliva. See refs. [2, 32, 33]. Saliva production was modeled at 4 and 2Â ml/minBack to article page